1258 results
-
List item
News: EMA recommends non-renewal of authorisation of multiple myeloma medicine Blenrep (updated)
CHMP, Last updated: 28/09/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 11-14 September 2023 (new)
CHMP, Last updated: 15/09/2023 -
List item
News: EMA recommends non-renewal of authorisation of Duchenne muscular dystrophy medicine Translarna (new)
CHMP, Last updated: 15/09/2023 -
List item
News: Spikevax: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5 (new)
CHMP, Last updated: 14/09/2023 -
List item
News: Comirnaty: EMA recommends approval of adapted COVID-19 vaccine targeting Omicron XBB.1.5
CHMP, Last updated: 30/08/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 17-20 July 2023
CHMP, Last updated: 21/07/2023 -
List item
News: First RSV vaccine to protect infants up to 6 months of age and older adults
CHMP, Last updated: 21/07/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 19-22 June 2023
CHMP, Last updated: 23/06/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 22-25 May 2023
CHMP, Last updated: 26/05/2023 -
List item
News: Revocation of authorisation for sickle cell disease medicine Adakveo
CHMP, Last updated: 09/08/2023 -
List item
News: First vaccine to protect older adults from respiratory syncytial virus (RSV) infection
CHMP, Last updated: 26/04/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24 - 26 April 2023
CHMP, Last updated: 26/05/2023 -
List item
News: EU recommendations for 2023-2024 seasonal flu vaccine composition
CHMP, Last updated: 04/04/2023 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 27 - 30 March 2023
CHMP, Last updated: 31/03/2023 -
List item
News: EMA recommends approval of Bimervax as a COVID-19 booster vaccine
CHMP, Last updated: 30/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 27-30 March 2023
European Medicines Agency, Amsterdam, the Netherlands, from 27/03/2023 to 30/03/2023, Last updated: 22/05/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 27-30 January 2025
European Medicines Agency, Amsterdam, the Netherlands, from 27/01/2025 to 30/01/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 February 2025
European Medicines Agency, Amsterdam, the Netherlands, from 24/02/2025 to 27/02/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 March 2025
European Medicines Agency, Amsterdam, the Netherlands, from 24/03/2025 to 27/03/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 22-25 April 2025
European Medicines Agency, Amsterdam, the Netherlands, from 22/04/2025 to 25/04/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 May 2025
European Medicines Agency, Amsterdam, the Netherlands, from 19/05/2025 to 22/05/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 June 2025
European Medicines Agency, Amsterdam, the Netherlands, from 16/06/2025 to 19/06/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 July 2025
European Medicines Agency, Amsterdam, the Netherlands, from 21/07/2025 to 24/07/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 18-21 August 2025
European Medicines Agency, Amsterdam, the Netherlands, from 18/08/2025 to 21/08/2025, Last updated: 10/03/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 15-18 September 2025
European Medicines Agency, Amsterdam, the Netherlands, from 15/09/2025 to 18/09/2025, Last updated: 10/03/2023